CD69

CD69 분자 정보

영어 이름Early activation antigen CD69시판 약물 수0
임상 약물 수0표적 별명
최고 연구 개발 단계Preclinical
영어 이름Early activation antigen CD69
표적 별명
시판 약물 수0
임상 약물 수0
최고 연구 개발 단계Preclinical

CD69 제품 목록

  • 속성

    Protein (1)Antibody (1)

  • 제품 라이브러리

    온라인 (2)

  • Human (1)Mouse (1)

  • 태그

    His Tag (1)- (1)

  • 마커

    Unconjugated (1)PE Labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
CD9-H5222
Human
HEK293
Human CD69 / CLEC2C Protein, His Tag
FABm022-01
Mouse
Hybridoma
PE-Labeled Monoclonal Anti-Human CD69 Antibody, Mouse IgG1 (3C5B7) (0.03% Proclin)
총 수량2
  • 1

CD69분자 배경

Early activation antigen CD69 is also known as C-type lectin domain family 2 member C (CLEC2C), Activation inducer molecule (AIM), Early T-cell activation antigen p60, Leukocyte surface antigen Leu-23. CD69 contains one C-type lectin domain. CD69 / CLEC2C is expressed on the surface of activated T-cells, B-cells, natural killer cells, neutrophils, eosinophils, epidermal Langerhans cells and platelets. CD69 is induced by antigens, mitogens or activators of PKC on the surface of T and B-lymphocytes and by interaction of IL-2 with the p75 IL-2R on the surface of NK cells. CD69 / CLEC2C involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.
  • 분자 정보
  • 제품 목록
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호